|
2023
|
Invention
|
Crystal form of substituted oxopyridine derivative and preparation method therefor. The present i... |
|
|
G/S
|
Chemical analysis; Chemical research; Chemical research services; Conducting of feasibility studi... |
|
|
Invention
|
Crystalline forms of benzamide compound and process for preparing the same.
The present disclosu... |
|
2022
|
Invention
|
Crystal form of azacyclobutyl nicotinic acid compound and preparation method therefor. The presen... |
|
|
Invention
|
Crystal form of pyridine derivative and preparation method therefor. A crystal form A of a compou... |
|
|
Invention
|
Crystal forms of pyridazine carboxamide compound and preparation method thereof. Crystal forms B,... |
|
|
Invention
|
Crystal form of oxodihydroimidazopyridine compound and preparation method therefor. The present i... |
|
|
Invention
|
New crystal form of hydrochloride of pyrazole-substituted nicotinamide compound and preparation m... |
|
|
Invention
|
Crystal forms of sulfamoyl pyrrole amide compounds and preparation methods therefor. Provided are... |
|
2021
|
Invention
|
Crystal forms of hemifumarate salt of carboxylic acid compound and preparation method therefor. P... |
|
|
Invention
|
Crystal forms of pyrrole derivative compound and preparation method therefor. The present inventi... |
|
|
Invention
|
Crystalline forms of quinazolinone compound and process for preparing the same.
Provided are a c... |
|
|
Invention
|
New crystal forms of quinazolinone derivative and preparation method therefor. Provided are a cry... |
|
|
Invention
|
New crystal forms of indole carboxamide compound and preparation method therefor. New crystal for... |
|
|
Invention
|
New crystal form of benzoic acid derivative and preparation method therefor. Provided are three c... |
|
|
Invention
|
Crystal forms of benzamide compounds and preparation method therefor. The present invention relat... |
|
|
Invention
|
Malonate crystal form of propenone compound, and preparation method therefor. A crystal form of a... |
|
|
Invention
|
New crystal form of benzamide compound and dihydrochloride thereof, and preparation method theref... |
|
|
Invention
|
New crystal form of p-toluenesulfonate salt of diazabicyclic compound and preparation method ther... |
|
|
Invention
|
Novel crystal form of benzothiazole compound and preparation method therefor. The present inventi... |
|
|
Invention
|
Crystal forms of (2e)-n-[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-piperi... |
|
|
Invention
|
Crystalline forms of a sulfonamide compound and processes for preparing the same.
The present in... |
|
|
Invention
|
Crystal forms of sulfonamide compound and preparation method therefor. The present invention rela... |
|
2019
|
Invention
|
Crystalline form of lenvantinib mesylate and process of preparation thereof. The present disclosu... |
|
2018
|
Invention
|
Crystal form of monosuccinate of ribociclib and preparation method and use thereof. Provided are ... |
|
|
Invention
|
Salt of pyrrolo[2,3-d]pyrimidine compound and novel polymorph of salt. The present invention rela... |
|
|
Invention
|
Crystalline forms of trisodium supramolecular complex comprising valsartan and ahu-377 and method... |
|
2017
|
Invention
|
Crystalline forms of ap26113, and preparation method thereof. The present disclosure relates to t... |
|
|
Invention
|
Novel ap26113 crystals and preparation method therefor. The present invention relates to two AP26... |
|
|
Invention
|
Crystal form of adenosine a2a receptor antagonist drug and preparation method and use thereof. A ... |
|
|
Invention
|
Crystalline form e of tafamidis meglumine, process for preparation and use thereof. The present d... |
|
|
Invention
|
Crystalline form e of tafamidis meglumine, process for preparation and use thereof. The present i... |
|
|
Invention
|
Crystalline form e of tafamidis methylglucamine salt, and preparation method and application ther... |
|
|
Invention
|
Hydrochloride salt crystal of drug for treating or preventing jak-associated disease and preparat... |
|
|
Invention
|
Ahu377 crystal forms, and preparation method therefor and use thereof. The present invention rela... |
|
|
Invention
|
Crystalline form a of 2-[(2r)-2-methyl-2-pyrrolidyl]-1h-benzimidazole-7-carboxamide dihydrochlori... |
|
|
Invention
|
Crystalline forms of (6-(1h-indazol-6-yl)-n-[4-(4-(4-morpholinyl)phenyl]imidazo[1,2-a]pyrazin-8-a... |
|
2016
|
Invention
|
Crystalline forms of selective s1p1 receptor modulator and preparation method thereof. The presen... |
|
|
Invention
|
Preparation method for eutectic hydrate crystal form ii of ahu-377 and diovan trisodium salt. The... |
|
|
Invention
|
Crystal form of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxole-5-yl)cyclopropane formamido)-3-methylpy... |
|
|
Invention
|
Crystal form of lenvatinib methanesulfonate salt and preparation method thereof. The present disc... |
|
|
Invention
|
Co-crystal of a cdk inhibitor and an mek inhibitor and process of preparation thereof. The presen... |
|
|
Invention
|
Crystalline form of ahu377, preparation method and use thereof. The present disclosure relates to... |
|
|
Invention
|
Preparation method of crystalline form a of pci-32765. A preparation method of PCI-32765 crystall... |
|
|
Invention
|
Crystal form of jak inhibitor and preparation method thereof. The present disclosure relates to n... |
|
|
Invention
|
Crystalline form alpha of ipi-145 and preparation method thereof. The present disclosure relates ... |
|
|
Invention
|
Crystal form of neratinib maleate and preparation method therefor. The present invention relates ... |
|
2015
|
Invention
|
Crystalline form a of obeticholic acid and preparation method thereof. The present invention rela... |
